BSE filing, BSE: 544460. Summary written from the filing by ALFA Finder's alert engine.
Patel Chem Specialities Ltd: key numbers
- Share price
- ₹140.00
- Market cap
- ₹348.2 Cr
- Revenue (annual)
- ₹137.3 Cr
- Net profit (annual)
- ₹12.55 Cr
- P/E (TTM)
- 27.7×Sector 46.1×
- Promoter holding
- 68.90%
- FII holding
- 5.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Patel Chem Specialities Ltd
All →Patel Chem Specialities Board Meeting Date
Patel Chem Specialities has scheduled its board meeting for November 5, 2026, to approve H1 unaudited financial results. No financial figures are disclosed in this advance intimation.
Patel Chem Specialities Other Announcement
This is a quarterly shareholding pattern filing for Patel Chem Specialities Ltd for the period ending September 30, 2026, as required under Regulation 31.
Patel Chem Specialities Business Update
Patel Chem Specialities completed Talod plant expansion, scaling capacity from 720 to 4,500 MTPA. Trial batches have commenced; commercial production expected shortly.
- manufacturing capacity
- 4500 MTPA
Patel Chem Specialities Business Update
Patel Chem Specialities completed its Talod plant expansion, raising capacity from 750 to 4,500 MT per annum. Commercial production is expected shortly.
- Value
- ₹20.00 Cr
- MCCP manufacturing capacity
- 4500 MT per annum
Patel Chem Specialities Promoter Buying (Off-Market)
Promoter group member Devansh Bhupesh Patel acquired 1,200 equity shares of the company through an off-market transfer from Tulsi Chauhan.
Patel Chem Specialities Annual General Meeting
Patel Chem Specialities Limited conducted its 18th Annual General Meeting on September 25, 2026. Shareholders approved the audited financial statements, director re-appointments, and related party transactions.
Other board meeting date announcements
All →Augmont Enterprises Board Meeting Date
Augmont Enterprises scheduled a Board meeting for November 4, 2026, to approve unaudited Q1 and H1 financial results. Trading window remains closed until 48 hours post-declaration.
Linc Board Meeting Date
Linc Ltd announced that its Board of Directors meeting is scheduled for 5 November 2026. The agenda includes approval of unaudited financial results for Q1 and H1 FY27.
NDR Auto Components Board Meeting Date
NDR Auto Components intimated its board meeting for November 4, 2026, to approve Q1 and H1 FY27 results. No financial figures are reported.
Reliance Chemotex Industries Board Meeting Date
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.
Andhra Sugars Board Meeting Date
The Andhra Sugars Limited intimated a board meeting on 07 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 09 Nov 2026.
Inventure Growth & Securities Board Meeting Date
Inventure Growth & Securities Limited intimated a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated quarterly financial results for September 2026. Trading window closes 06 Nov 2026.